切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2019, Vol. 08 ›› Issue (04) : 358 -362. doi: 10.3877/cma.j.issn.2095-3224.2019.04.007

所属专题: 文献

论著

缺氧诱导BCL9促进结肠癌细胞的增殖与迁移
臧佳1, 谢亚运1, 李新星1, 张言言1, 胡志前1,()   
  1. 1. 200003 上海长征医院普外一科
  • 收稿日期:2018-10-11 出版日期:2019-08-25
  • 通信作者: 胡志前

Hypoxia induce BCL9 promote colorectal cancer proliferation and migration

Jia Zang1, Yayun Xie1, Xinxing Li1, Yanyan Zhang1, Zhiqian Hu1,()   

  1. 1. Department of General Surgery, Shanghai Changzheng Hospital, 200003 Shanghai, China
  • Received:2018-10-11 Published:2019-08-25
  • Corresponding author: Zhiqian Hu
  • About author:
    Corresponding author: Hu Zhiqian, Email:
引用本文:

臧佳, 谢亚运, 李新星, 张言言, 胡志前. 缺氧诱导BCL9促进结肠癌细胞的增殖与迁移[J/OL]. 中华结直肠疾病电子杂志, 2019, 08(04): 358-362.

Jia Zang, Yayun Xie, Xinxing Li, Yanyan Zhang, Zhiqian Hu. Hypoxia induce BCL9 promote colorectal cancer proliferation and migration[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2019, 08(04): 358-362.

目的

探索缺氧对B-淋巴细胞瘤蛋白9(BCL9)的调控关系及BCL9对结肠癌细胞的生物学作用。

方法

收取20例结肠癌标本及同一患者的正常结肠标本,利用免疫组化技术、实时荧光定量PCR技术检测BCL9的表达;利用常氧或缺氧培养HCT116细胞,实时荧光定量PCR及蛋白印迹法(western-blot)检测BCL9的表达;构建包含BCL9启动子序列的荧光素酶报告载体,通过缺氧处理或过表达HIF1α,检测荧光素酶活性变化;通过过表达质粒或siRNA干扰BCL9的表达,随后检测HCT116细胞的增殖活性及迁移能力。

结果

免疫组化及实时荧光定量PCR检测显示肿瘤组织中BCL9表达明显高于正常组织[(3.25±0.53)vs.(1.03±0.12),P<0.05];缺氧培养HCT116细胞后BCL9的表达显著提高,[(6.71±0.83)vs.(1.54±0.21),P<0.05];同时,缺氧培养或过表达HIF1α能显著提高荧光素酶的活性[(3.53±0.75)vs.(0.96±0.15),(4.83±0.62)vs.(1.02±0.14);P<0.05];干扰BCL9的表达抑制HCT116细胞的增殖及迁移能力[(1.23±0.12)vs.(1.87±0.15),P<0.05];提高BCL9表达能促进HCT116细胞的增殖及迁移能力[(2.43±0.16)vs.(1.81±0.14),P<0.05]。

结论

缺氧可诱导BCL9在结肠癌中高表达,并通过BCL9促进结肠癌细胞增殖、迁移。

Objective

The purpose of the paper was to explore the regulation relationship between hypoxia and BCL9 in colorectal cancer cells and whether the BCL9 can influence the function of colorectal cancer cells.

Methods

Detected BCL9 in 20 cases of colorectal cancer and the normal colorectal tissue by immunohistochemistry and RT-qPCR; Assay the BCL9 expression in colorectal cancer cells under hypoxia condition or normoxia condition by RT-PCR and western-blot; Constructed luciferase plasmid which contain of the promoter of BCL9, by given the hypoxia condition to induce endogenous HIF-1α or use over-expression plasmid induced exogenous HIF-1α in HCT116 cells to explored the regulate relationship between HIF-1α and LDHA; Middle the expression of BCL9 by over-expression plasmid and siRNA, and detected the proliferation and migration by CCK8 assay and transwell assay.

Results

BCL9 is always over-expression in colorectal cancer [(3.25±0.53) vs. (1.03±0.12), P<0.05]; By given oxygen condition, we found that hypoxia can induce BCL9 over-expression in colorectal cancer cells [(6.71±0.83) vs.(1.54±0.21), P<0.05]; Both hypoxia and over-expression exogenous HIF-1α leaded luciferase activity enhanced; Using RNA interfere technique to knockdown the expression of HIF-1α will suppression LDHA expression [(3.53±0.75) vs. (0.96±0.15), (4.83±0.62) vs. (1.02±0.14); P<0.05]; Interfere the expression of BCL9 suppresion HCT116 cells proliferation and migration [(1.23±0.12) vs. (1.87±0.15), P<0.05]; On the other hand, over-expression BCL9 leaded to the opposite result [(2.43±0.16) vs. (1.81±0.14), P<0.05];

Conclusion

Hypoxia induce BCL9 over-expression and promote HCT116 cells proliferation and migration.

图1 肿瘤组织与正常组织的免疫组化与实时荧光定量PCR。1A:免疫组织化疗结果显示,肿瘤组织的BCL9表达量明显高于正常组织(10倍镜与40倍镜下);1B:实时荧光定量PCR检测发现BCL9 RNA的表达明显高于正常组织,P<0.05,差异具有统计学意义
图2 HIF1α调控BCL9表达。2A:BCL9启动子区缺氧诱导原件(HER)的分布;2B:实时荧光定量PCR检测BCL9 RNA的表达;2C:western-blot检测BCL9、HIF1α的表达;2D、2E:荧光素酶活性检测。代表P<0.05,差异具有统计学意义
图3 BCL9对结肠癌细胞增殖和迁移能力的影响。3A:实时荧光定量PCR检测BCL9干预效率;3B:CCK8实验检测干预BCL9后HCT116的增殖活性;3C、3D:Transwell实验检测干预BCL9后HCT116的增殖活性。代表P<0.05,差异具有统计学意义
[1]
Chapman-Smith A, Lutwyche JK, Whitelaw ML. Contribution of the Per/Arnt/Sim (PAS) domains to DNA binding by the basic helix- loop-helix PAS transcriptional regulators [J]. J Biol Chem, 2004, 279(7): 5353-5362.
[2]
Pugh CW, Tan CC, Jones RW, et al. Functional analysis of an oxygen-regulated transcriptional enhancer lying 3′ to the mouse erythropoietin gene [J]. Proc Natl Acad Sci USA, 1991, 88(23): 10553-10557.
[3]
Semenza GL. Targeting HIF-1 for cancer therapy [J]. Nat Rev Cancer, 2003, 3(10): 72l-732.
[4]
Brahimi-Horn C, Pouysségur J. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion [J]. Bull Cancer, 2006, 93(8): E73-E80.
[5]
Mieszczane KJ, de la Roche M, Bienz M. A role of Pygopus as an anti-repressor in facilitating Wnt-dependent transcription [J]. Proceedings of the National Academy of Sciences of the United States of America, 2008, 105(49): 19324-19329.
[6]
Mani M, Carrasco DE, Zhang Y, et al. BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells [J]. Cancer research, 2009, 69(19): 7577-7586.
[7]
Hyeon J, Ahn S, Lee JJ, et al. Prognostic significance of BCL9 expression in hepatocellular carcinoma [J]. Korean Journal of Pathology, 2013, 47(2): 130-136.
[8]
Brenner H, Kloor M, Pox CP. Colorectal cancer [J]. Lancet, 2014, 383(9927): 1490-1502.
[9]
Brembeck FH, Rosario M, Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin [J]. Current Opinion in Genetics & Development, 2006, 16(1): 51-59.
[10]
Kramps T, Peter O, Brunner E, et al. Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex [J]. Cell, 2002, 109(1): 47-60.
[11]
Katoh M, Katoh M. WNT signaling pathway and stem cell signaling network [J]. Clinical Cancer Research, 2007, 13(14): 4042-4045.
[12]
Krishnamachary B, Zagag D, Nagasawa H, et al. Hypoxia-inducible factor-1 -dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor null renal cell carcinoma mediated by TCF3 , ZFHX1A and ZFH X1B [J]. Cancer Res, 2006, 66(5): 2725-2731.
[13]
Munoz Najar UM, Neurath KM, Vumbaca F, et al. H ypoxia stimulates breast carcinoma cell invasion through MT1 MMP and MMP2 activation [J]. Oncogene, 2006, 25(16): 2379-2392.
[14]
Ke Q, Costa M. Hypoxia-inducible factor-1(HIF-1) [J]. Mol Pharmacol, 2006, 70(5): 1469-1480.
[1] 钟雅雯, 王煜, 王海臻, 黄莉萍. 肌苷通过抑制线粒体通透性转换孔开放缓解缺氧/复氧诱导的人绒毛膜滋养层细胞凋亡[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 525-533.
[2] 黄福, 王黔, 金相任, 唐云川. VEGFR2、miR-27a-5p在胃癌组织中的表达与临床病理参数及预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 558-561.
[3] 崔宏帅, 冯丽明, 东维玲, 韩博. 腹腔镜右半结肠癌D3根治术+IGLN清扫术治疗局部进展期结肠肝曲癌的临床效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 566-569.
[4] 丁志翔, 于鹏, 段绍斌. 血浆BRAF基因检测对腹腔镜右半结肠癌D3根治术中行幽门淋巴结清扫的指导价值[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 570-573.
[5] 王维花, 王楠, 乔庆, 罗红. 完全腹腔镜右半结肠癌切除术两种腔内消化道重建方案对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 574-577.
[6] 祝炜安, 林华慧, 吴建杰, 黄炯煅, 吴婷婷, 赖文杰. RDM1通过CDK4促进前列腺癌细胞进展的研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 618-625.
[7] 胡思平, 熊性宇, 徐航, 杨璐. 衰老相关分泌表型因子在前列腺癌发生发展中的作用机制[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 425-434.
[8] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[9] 何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687.
[10] 关国欣, 罗福文. 结肠癌合并急性梗阻的个性化处理[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 459-463.
[11] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
[12] 崔精, 鲍一帆, 沈晓明, 杨增辉, 高森, 鲍传庆. 结直肠癌中circMFSD12对肿瘤细胞功能及5-FU敏感性的调控[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 294-302.
[13] 王国强, 张纲, 唐建坡, 张玉国, 杨永江. LINC00839 调节miR-17-5p/WEE1 轴对结直肠癌细胞增殖、凋亡和迁移的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 491-499.
[14] 靳英, 付小霞, 陈美茹, 袁璐, 郝力瑶. CD147调控MAPK信号通路对结肠癌细胞增殖和凋亡的影响及机制研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 474-480.
[15] 傅新露, 李之岳, 卢丹. 妊娠合并结肠癌穿孔致脓毒症休克一例并文献复习[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 227-231.
阅读次数
全文


摘要